Thursday, April 23, 2009
Pfizer’s Enhanced Clinical Trial Design Saves $100 Million Annually
Dr. Michael McKelvey, CEO of
, a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, discusses the benefits of electronic patient reported outcomes (ePRO) tools for assessing and monitoring suicidality in clinical drug trials.
In what CEO M. Denis Connaghan called a “challenging year,” eClinical company etrials reported a decrease in year-end revenue and an operating loss for the year.
Clinical Trials and Surveys Corp (C-TASC), a clinical trials solutions company, hired three new biostatisticians and plans to double its staff in the next year. The company, which currently employs 35 people, plans to increase to 60 employees by February 2010 in order to keep up with increased demand for its clinical trial services and technologies.